Skip to main content

Full Schedule

Full Schedule

  • Wednesday, November 1, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome and Introduction
  • 8:15 AM – 8:50 AM ET
    Session 1: Updates in Rare Ovarian Cancers (Low Grade, Non-Serous Epithelial and Non-Epithelial)
  • 8:50 AM – 9:00 AM ET
    Live Q&A
  • 9:00 AM – 9:15 AM ET
    Break
  • 9:15 AM – 10:00 AM ET
    Session 2: Assessment and Intervention for Chemotherapy-Induced Neuropathy and Myopathy
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 11:15 AM ET
    Non-CME Innovation Theater
  • 11:15 AM – 11:30 AM ET
    Break
  • 11:30 AM – 12:05 PM ET
    Session 3: Management and Challenges of Cervical Cancer Treatment in the Second Line and Beyond
  • 12:05 PM – 12:15 PM ET
    Live Q&A
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:15 PM ET
    Session 4: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:30 PM ET
    Non-CME Innovation Theater
  • 2:30 PM – 2:45 PM ET
    Break
  • 2:45 PM – 3:20 PM ET
    Session 5: Updates in Front Line Adjuvant and Metastatic Treatment of Endometrial Cancer
  • 3:20 PM – 3:30 PM ET
    Live Q&A
  • 3:30 PM – 3:45 PM ET
    Break
  • 3:45 PM – 4:20 PM ET
    Session 6: Emerging Developments in Recurrent (2L and beyond) Endometrial Cancer
  • 4:20 PM – 4:30 PM ET
    Live Q&A
  • 4:30 PM – 4:45 PM ET
    Break
  • 4:45 PM – 5:20 PM ET
    Session 7: Updates in Molecular Testing and Front-Line Treatment in Ovarian Cancer
  • 5:20 PM – 5:30 PM ET
    Live Q&A